Former Yahoo! Chairman, Wall Street Titan Roy J. Bostock Joins GID BIO as Chair

GID BIO completed an FDA compliant, multi-site, randomized, placebo-controlled Phase IIb clinical trial using autologous stromal cells in the treatment of knee osteoarthritis (OA), successfully meeting endpoints and two-year safety results…

Read more via ORTHOWORLD: https://www.orthoworld.com/index.php/publications/orthoflash/gid-bio-completes-trial-of-stromal-cells-to-treat-knee-oa

Share the news using the buttons below
Facebook
Pinterest
Twitter
LinkedIn

Newsletter

Signup our newsletter to get updated information, and insight about GID BIO

Latest article

Skip to content